Pasithea Therapeutics Corp. (KTTA) Stock Price & Analysis

Pasithea Therapeutics Corp. (KTTA) rose 0.00% to USD 0.46 as of July 25, 2026 at 02:22 UTC, according to Nexqual real-time market data.

KTTA last closed at USD 0.46; the session ranged USD 0.45–0.5 on volume of 325,168 shares. Market capitalization is —, with a 52-week range of USD 0.28–2.06 (NCM). Source: Nexqual, July 25, 2026 at 02:22 UTC.

Key Statistics (as of July 25, 2026 at 02:22 UTC)

Technical Analysis (KTTA)

Nexqual's technical model rates KTTA "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 02:22 UTC.

From Pasithea Therapeutics Corp.'s Latest SEC 10-K Filing (filed 2026-03-30)

Key Strengths & Strategy (as disclosed to the SEC)

• Our policy is to actively seek to obtain, where appropriate, the broadest intellectual property protection possible for our current product candidates and any future product candidates, proprietary information and proprietary technology through a combination contractual arrangements and patents, both in the United States and abroad.
• While we believe that our technology, development experience and scientific knowledge provide us with competitive advantages, we face potential competition from many different sources, including major pharmaceutical, specialty pharmaceutical, and biotechnology companies, academic institutions, governmental agencies and public and private research institutions.

Partnerships

• To date, we have created over 100 analogs of our 20 priority hits as provided via our past screening partnership with Evotec.
• The terms of the Alpha-5 Agreement were approved by (i) the disinterested members of the audit committee ("Audit Committee") of Board and (ii) the disinterested members the Board, under the Company's related party transaction policy.   In connection with the Alpha-5 Agreement, each of the employees of Alpha-5 entered into employment agreements with the Company.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:22 UTC. This page is informational and not investment advice.